
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>104-190</title>
    </head>

    <body>
        <h1>
        <a href="./104_189.html" rel="external" title="prev">≪</a>
        104-190
        <a href="./104_191.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>19歳女性。高校生の頃から、気がつくと授業中に眠っていることがしばしばあったが、夜間に受験勉強に励んでいることが原因と思っていた。大学に入学後も、授業中に突然眠ってしまったり、夜間に悪夢を見たりした。眠気により食生活が不規則にもなった。</p>
<p>心配になり、友人や家族に相談したところ病院受診を勧められた。診察及び検査の結果、ナルコレプシーと診断され、処方1及び2で3ヶ月治療されたが、症状が改善されないため、処方1が処方3に変更となった。</p>
<p><img alt="" class="alignnone size-full wp-image-778" height="223.29999999999998" loading="lazy" sizes="(max-width: 639px) 100vw, 639px" src="data:;base64,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" width="447.29999999999995"/></p>
<h4>問190</h4>
<p>本症例に関する病態、検査及び薬物療法に関する記述のうち、正しいのはどれか。2つ選べ。</p>
<ol><li>睡眠時ポリグラフ検査や反復睡眠潜時検査が、診断に有用である。</li><li>メチルフェニデート塩酸塩の代わりにアトモキセチン塩酸塩を用いることができる。</li><li>処方3の薬剤は、処方1の薬剤より依存性が高い。</li><li>クロミプラミン塩酸塩は、REM睡眠関連症状の改善のために使用される。</li><li>日中覚醒できていれば、食生活と睡眠習慣の改善は推奨しない。</li></ol>
<div class="information-box common-icon-box">この問題は正しい選択肢が3つあるため、いずれか2つを選べば正解となりました。</div>
<h4>問191</h4>
<p>前問の処方2及び3の薬物の作用機序として、正しいのはどれか。2つ選べ。</p>
<ol><li>γ-アミノ酪酸GABA<sub>A</sub>受容体遮断</li><li>ドパミン及びノルアドレナリンの再取り込み阻害</li><li>ノルアドレナリン及びセロトニンの再取り込み阻害</li><li>アデノシンA<sub>2A</sub>受容体遮断</li><li>ニコチン性アセチルコリン受容体刺激</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問190：1, 3, 4問191：2, 3
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問190</h4>
<p><span style="font-weight: 400;">選択肢 1 は妥当な記述です。</span></p>
<p><span style="font-weight: 400;">選択肢 2 ですが<br/></span><span style="font-weight: 400;">アトモキセチン（ストラテラ）は、AD/HD 治療薬です。ナルコレプシーに用いる薬ではありません。よって、選択肢 2 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 3,4 は妥当な記述です。</span></p>
<p><span style="font-weight: 400;">選択肢 5 ですが<br/></span><span style="font-weight: 400;">暴飲暴食を避ける、同じ時間に睡眠をとるといった習慣改善が推奨されます。よって、選択肢 5 は誤りです。</span></p>
<p><span style="font-weight: 400;">以上より、問190 は、1,3,4 が正しい選択肢となります。<br/></span><span style="font-weight: 400;">本問は「正答が 1,3,4、このうち 2 つ選択なら正解」でした。</span></p>
<h4>問191</h4>
<p><span style="font-weight: 400;">クロミプラミン（アナフラニール）は脳内セロトニン 及び ノルアドレナリンの取り込み阻害により作用を示すとされています。</span></p>
<p><span style="font-weight: 400;">メチルフェニデート（リタリン、コンサータ）は、ドパミンおよびノルエピネフリントランスポーターに結合し、再取り込みを抑制して作用を示すとされています。</span></p>
<p><span style="font-weight: 400;">以上より、問191 の正解は 2,3 です。</span></p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    